Abstract:Background: There is growing evidence of associations between the gut microbiota and anxiety disorders, where changes in gut microbiotas may affect brain function and behavior via the microbiota-gut-brain axis. However, population-level studies offering a higher level of evidence for causality are lacking. Our aim was to investigate the specific gut microbiota and associated metabolites that are closely related to anxiety disorders to provide mechanistic insights and novel management perspectives for anxiety disorders. Method: This study used summary-level data from publicly available Genome-Wide Association Studies (GWAS) for 119 bacterial genera and the phenotype "All anxiety disorders" to reveal the causal effects of gut microbiota on anxiety disorders and identify specific bacterial genera associated with anxiety disorders. A two-sample, bidirectional Mendelian randomization (MR) design was deployed, followed by comprehensive sensitivity analyses to validate the robustness of results. We further conducted multivariable MR (MVMR) analysis to investigate the potential impact of neurotransmitter-associated metabolites, bacteria-associated dietary patterns, drug use or alcohol consumption, and lifestyle factors such as smoking and physical activity on the observed associations. Results: Bidirectional MR analysis identified three bacterial genera causally related to anxiety disorders: the genus Eubacterium nodatum group and genus Ruminococcaceae UCG011 were protective, while the genus Ruminococcaceae UCG011 was associated with an increased risk of anxiety disorders. Further MVMR suggested that a metabolite-dependent mechanism, primarily driven by tryptophan, tyrosine, phenylalanine, glycine and cortisol, which is consistent with previous research findings, probably played a significant role in mediating the effects of these bacterial genera to anxiety disorders. Furthermore, modifying dietary pattern such as salt, sugar and processed meat intake, and adjusting smoking state and physical activity levels, appears to be the effective approaches for targeting specific gut microbiota to manage anxiety disorders. Conclusion: Our findings offer potential avenues for developing precise and effective management approaches for anxiety disorders by targeting specific gut microbiota and associated metabolites.

The interactions between host genome and gut microbiome increase the risk of psychiatric disorders: Mendelian randomization and biological annotation

Causal effects of gut microbiota on the risk of bipolar disorder: a Mendelian randomization study

Gut microbiome and schizophrenia: insights from two-sample Mendelian randomization

Causal effect of the gut microbiota on the risk of psychiatric disorders and the mediating role of immunophenotypes

Host genetics influences the relationship between the gut microbiome and psychiatric disorders

Associations between gut microbiota and Alzheimer’s disease, major depressive disorder, and schizophrenia

Gut microbiome and major depressive disorder: insights from two-sample Mendelian randomization

Genetic associations and potential mediators between psychiatric disorders and irritable bowel syndrome: a Mendelian randomization study with mediation analysis

Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders

Causal relationships between gut microbiota and depression/anxiety disorders: A 2-sample Mendelian randomization study.

Association between psychiatric disorders and irritable bowel syndrome: A bidirectional Mendelian randomization study

Causal link between gut microbiome and schizophrenia: a Mendelian randomization study

Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study

Dissecting the shared genetic landscape of anxiety, depression, and schizophrenia

Anorexia nervosa and bulimia nervosa: a Mendelian randomization study of gut microbiota

The influence of gut microbiota on circulating inflammatory cytokines and host: A Mendelian randomization study with meta-analysis

Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders

Gut microbiota and cognitive performance: A bidirectional two-sample Mendelian randomization

Improving precision management of anxiety disorders: a Mendelian randomization study targeting specific gut microbiota and associated metabolites

The host genetics affects gut microbiome diversity in Chinese depressed patients

Impact of psychiatric disorders on the risk of glioma: Mendelian randomization and biological annotation